octurnal ventilatory support in obesity hypoventilation syndrome.

Completed

• Conditions: Obesity hypoventilation syndrome; Diet and Nutrition - Obesity; Cardiovascular - Other respiratory disorders / diseases

• Registration Number: ACTRN12605000096651
• Lead Sponsor: Woolcock Institute of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-05
• Study Completion: 2011-10-27
• Last Update Posted: 23 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

BMI 30 or above; PaCo2 45mm Hg or above; without major lung or neuromuscular disease to explain awake hypoventilation.

Exclusion Criteria

Clinical instability, major psychiatric disorder, patients already using CPAP or bilevel therapy, inability to read or understand the patient information or consent forms.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in awake arterial blood gases after 3 months of therapy compared to baseline[3 months]

Secondary Outcome Measures

Name	Time	Method
eurocognitive function (including psychomotor vigilance test).[3 months];Quality of life[3 months];Sleep quality[3 months];Compliance with therapy[Measured after 3 months on therapy.]